| Active ingredient |
10 mg/20 mg capsules of isotretinoin |
10 mg/20 mg capsules of isotretinoin |
| Manufacturer |
Generic (produced by companies such as Abexor, or other generic manufacturers) |
Brand‑name product (originally from Pfizer, now produced under license by various manufacturers) |
| Formulation |
Identical therapeutic dose; excipients may differ (e.g., different binders, fillers, or coatings) but are chosen to meet FDA/EMA bioequivalence standards. |
Same therapeutic dose; excipients may differ slightly but are also FDA/EMA‑approved. |
| Bioequivalence |
Certified as bioequivalent to the brand product by regulatory agencies (i.e., the drug is absorbed at the same rate and extent). |
The reference brand, therefore the “gold standard” for bioequivalence. |
| Availability |
Widely available at lower cost, often covered by more insurance plans and pharmacy discount programs. |
More expensive; may have limited insurance coverage or require prior authorization. |
| Patient support |
Generic manufacturers typically do not provide the same dedicated patient‑support programs that the brand did (e.g., no “Accutane® Support” website or hotline). |
Historically had a dedicated Accutane patient support program (now often transferred to the generic manufacturer or discontinued). |
| Pricing |
1‑2 × less than Accutane (exact savings vary by insurer, pharmacy, and region). |
Premium price, often the most expensive isotretinoin product on the market. |
| Brand loyalty / perception |
Some clinicians and patients prefer the brand name for its long history, but the generic has proven efficacy and safety. |
Brand name has a long reputation and many clinicians are familiar with it; some patients feel more comfortable with the original. |
| Side‑effect profile |
Identical; the same potential for dryness, mood changes, teratogenicity, etc. |
Identical. |
| Pregnancy precautions |
Same strict teratogenic precautions (e.g., 2 × negative pregnancy tests before therapy, monthly tests, contraception). |
Same strict teratogenic precautions. |
| Monitoring |
Labs (lipids, liver enzymes, pregnancy test) and follow‑up visits identical to brand. |
Same monitoring. |
| Dosing guidelines |
Same: typically 0.5–1 mg/kg/day divided into two doses, adjusted for weight and response; usually 5–20 mg capsules. |
Same. |